neobookRx
DrugsLevel 4 LocalisationS4SUSEML

Bovine Lipid Extract Surfactant

Natural surfactantSurfactant

Indications

Registered South African indications:

  • Respiratory distress syndrome

Cautions

Contraindications

  • Pulmonary haemorrhage

Cautions

  • Pregnancy 
  • Renal impairment
  • Hepatic impairment
  • Unstable infants
  • Persistent pulmonary hypertension
  • Birthweight <380g and >4460g

Adult dosage

Not indicated for use in adults

Paediatric dosage

Paed. forms avail. in SA and covered in this monograph: sus

Respiratory distress syndrome
-Hyaline membrane disease in premature newborns

  • Endotracheal (sus): 135mg/kg immediately; Repeat if needed; Max: 3 doses/5 days
Weight Total dose Weight Total dose Weight Total dose Weight Total dose
g ml g ml g ml g ml
600-650 3.2 951-1000 5.0 1301-1350 6.8 1651-1700 8.5
651-700 3.5 1001-1050 5.2 1351-1400 7.0 1701-1750 8.8
701-750 3.8 1051-1100 5.5 1401-1450 7.2 1751-1800 9.0
751-800 4.0 1101-1150 5.8 1451-1500 7.5 1801-1850 9.2
801-850 4.2 1151-1200 6.0 1501-1550 7.8 1851-1900 9.5
851-900 4.5 1201-1250 6.2 1551-1600 8.0 1901-1950 9.8
901-950 4.8 1251-1300 6.5 1601-1650 8.2 1950-2000 10.0

 

Warm vial to room temperature before use by holding vial in hand or by placing in water at 37 degrees celsius


Administer total dose as three aliquots: 1st with infant in supine position, 2nd/3rd with infant on left and then right side


Instillation of each aliquot should be followed by 30 seconds of manual ventilation


Allow 1-2 minutes of recovery between each aliquot


In unstable infants, especially with persistent pulmonary hypertension, total dose can be divided into 6 aliquots

Special populations

Adverse reactions

Central Nervous System Disorders

  • Interventricular haemorrhage
  • Periventricular leukomalacia
  • Convulsion
  • Hydrocephalus

Cardiovascular Disorders

  • Patent ductus arteriosus
  • Bradycardia
  • Hypotension

Respiratory Disorders

  • Decreased lung function
  • Pulmonary interstitial emphysema
  • Pneumothorax
  • Pulmonary haemorrhage
  • Apnoea
  • Pneumonia
  • Endotracheal tube obstruction

Gastrointestinal Disorders

  • Necrotising enterocolitis

Endocrine and Metabolic Disorders

  • Acidosis
  • Respiratory acidosis

Immune, Blood and Lymphatic System Disorders

  • Sepsis

Sensory Disorders

  • Retinopathy of prematurity

Interactions

No information available

Monitoring

  • Vital signs
  • Blood gas analysis

Mechanism of action

Liposurf is a natural surfactant sourced from bovine lungs containing mainly phospholipids and proteins. It acts by lining the internal surface of the lungs and decreasing the alveolar surface tension. This supports respiratory function by preventing collapse at end-expiration so that adequate gas exchange is maintained throughout the ventilatory cycle.

Dosage forms

  • Suspension

Formulation

Suspension (per ml) 27mg

  • Liposurf (Cipla) originator

References

1. https://drive.google.com/drive/folders/0B0xnChtF7vduZ2RtRTJuQ2pBQ0k (25/11/2011_Cipla_Liposurf_susp) *No SPC available

Brands & products

2 products · cached snapshot
Trade names (1)
  • Liposurf

SUSSuspension· 2 products

from R3881.77
ProductStrengthPackApplicantMin price
Liposurf27 mg/ml3Cipla Medpro (Pty) LtdR3881.77
Liposurf27 mg/ml5Cipla Medpro (Pty) LtdR6469.61

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

NeoHealth® ID 14957 · updated 11/25/2022